Overview:
Anvisa (the National Health Surveillance Agency), in partnership with the Foreign Trade Secretariat (Secex) and the Federal Revenue Service, has announced the integration of the payment of the Health Surveillance Fee into the Single Foreign Trade Portal (Siscomex). This change is part of a move to centralize and digitize foreign trade processes, offering more agility, transparency and simplicity for importers and exporters dealing with products subject to health surveillance.
Introduction:
Anvisa is integrating the payment of the Health Surveillance Inspection Fee (TFVS) and the import process protocol (LI/LPCO) into the Centralized Foreign Trade Payment (PCCE) module, accessible through the Single Foreign Trade Portal (Siscomex).
This integration aims to optimize the flow of information and simplify the payment of the fee, which is mandatory for the entry of goods that may impact public health. Check out the timetable and the main changes below.
What is the Sanitary Surveillance Fee?
The Sanitary Surveillance Fee (TFVS) is charged by Anvisa for the analysis and release of controlled products entering or leaving the country. Products such as food, medicines, cosmetics and medical devices must be inspected by Anvisa to ensure that they meet safety and quality requirements. Payment of the TFVS is therefore a crucial step for the release of imported products that are inspected by the agency.
How will integration with the Single Foreign Trade Portal work?
The Single Foreign Trade Portal (Siscomex) already centralizes a series of procedures for foreign trade, allowing users to access various functionalities on a single platform. With the integration, payment of the TFVS will now be made directly through the portal, simplifying the process and making it easier to monitor the payment status for the release of goods.
This change means that the importer or exporter will be able to manage all the stages of the process on Siscomex itself, unifying payment and avoiding the need to access different platforms. This provides greater security, reduces operating costs and makes the process faster.
Implementation schedule
Integration will be carried out in stages, and the initial schedule includes:
Phase 1: The integration of products considered to be of low risk to public health, scheduled for the first quarter of 2024. During this phase, the platform will be tested to verify usability and response time in the case of less critical products.
Phase 2: The inclusion of products with an intermediate level of health risk, planned for the second half of 2024. This phase will allow Anvisa and Siscomex to adjust the system based on the specific needs of these products.
Phase 3: Full integration of all products subject to health surveillance in foreign trade. Scheduled for the first half of 2025, this last phase will include high-risk products with more complex clearance requirements.
What are the Benefits for Companies and Foreign Trade Operators?
Simplification of processes: With integration, companies operating in foreign trade will be able to pay the tax more conveniently and quickly, reducing the number of steps required.
Greater Transparency and Control: All information and status updates will be centralized on the Single Foreign Trade Portal, facilitating real-time monitoring and allowing companies to make more informed decisions.
Cost Reduction: With less bureaucracy and operational steps, the expectation is for a reduction in the administrative costs of foreign trade operations.
Increased Competitiveness: By optimizing the process and reducing deadlines, companies will be able to respond more quickly to market demands, gaining an important competitive advantage in global trade.
Challenges and expectations
Despite the benefits, the implementation brings challenges, especially in terms of adapting to the new system and training operators. Integration will require an initial learning curve for the teams involved, but the expectation is that the changes will bring significant operational gains in the medium and long term.
Alignment between Anvisa, Secex and Receita Federal will be key to ensuring that the implementation schedule is adhered to and that any problems are resolved quickly.
Conclusion
The integration of the payment of the Health Surveillance Fee into the Single Foreign Trade Portal is an important step in the modernization of import and export processes in Brazil. With it, foreign trade tends to become more agile and competitive, benefiting companies and international trade operators who depend on faster and more efficient action from Anvisa. Keeping track of the implementation schedule is essential for companies to prepare for these changes, taking advantage of the operational gains that the integrated platform offers.
The import declaration is a very detailed process. If you want to import regulated health products into Brazil. GRP Brazil can support you.
Contact Us Today !
Learn more about
Brochure : GRP Brazil Services
GRP Brazil Office provides Regulatory Affairs, Quality, Clinical and Safety services to pharmaceutical, medical device, and life-consumers companies worldwide to register them product with ANVISA the local Health Authority (HA).
About Global Regulatory Partners
Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices, pharmaceutical, cosmetic and Food Supplement companies globally.
GRP headquarters is located in Massachusetts USA and its main affiliates are located in China, Japan, Brazil, and Mexico. GRP helps many life science companies register their products in different countries in compliance with local regulations.